The surrounding buzz is deafening, fuelled by incredible claims of effortless weight loss. But while berberine, or Daru Haldi ...

At the end of the study, the placebo group had a mean weight loss of 2.6 percent. Those on topiramate lost more weight. And, for the most part, the higher the dose, the more weight they lost.

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

There’s no such thing as "natural Ozempic." While supplements like psyllium, berberine, and glucomannan are paraded as ...

Explore the strongest prescription weight loss pills, their benefits and potential side effects. Plus, compare effective alternatives for dieting.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men. What’s not clear is why.

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

The latest study compares weight loss and side effects among people taking Wegovy or Zepbound.

There’s always a lot riding on these presentations, called readouts. But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught.